Yahoo Web Search

Search results

1. Outlook Therapeutics, Inc.

   NasdaqCM: OTLK

   7.74

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +0.42 (+5.74%)

   As of Mon. Jul 8, 2024 12:25 PM EDT · Nasdaq Real Time Price (USD) · Market open

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	7.37
     High	7.87
     Low	7.23

   • Mkt Cap	181.16M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	7.32
     52 Wk. Low	4.00
     52 Wk. High	37.00

   More about OTLK

   Top stories

   • OTLK
     +5.74%

   Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31% ownership, private equity firms own 31%

   Yahoo Finance · 3 weeks ago

   

   • COR
     +0.26%
   • CREX
     +0.72%
   • OTLK
     +5.74%
   • ESOA

   3 Undervalued Gems Set to Soar 1,000% by 2026

   Yahoo Finance · 2 weeks ago

   

   Related stocks

   • SEEL
     Seelos Therapeutics, Inc.
     SEEL
     0.5200
     -7.61%
   • VTGN
     Vistagen Therapeutics, Inc.
     VTGN
     3.4605
     +1.78%
   • VTVT
     vTv Therapeutics Inc.
     VTVT
     18.18
     +3.95%
   • GHSI
     Guardion Health Sciences, Inc.
     GHSI
     10.15
     +4.10%
   • ITRM
     Iterum Therapeutics plc
     ITRM
     1.2000
     +4.35%

   More on Yahoo Finance

2. finance.yahoo.com › quote › OTLKOutlook Therapeutics, Inc. (OTLK) Stock Price, News, Quote ...

   finance.yahoo.com › quote › OTLK

   • Cached

   Find the latest Outlook Therapeutics, Inc. (OTLK) stock quote, history, news and other vital information to help you with your stock trading and investing.

3. www.marketwatch.com › investing › stockOTLK Stock Price | Outlook Therapeutics Inc ... - MarketWatch

   www.marketwatch.com › investing › stock

   5 days ago · Outlook Therapeutics Inc. (OTLK) is a biotechnology company developing treatments for eye diseases. Get the latest stock quote, chart, news, earnings, analyst ratings and more on MarketWatch.

   • 1 Month: 10.17%
   • 5 Day: 7.34%

   • 3 Month: 4.52%
   • YTD: 10.28%

4. www.nasdaq.com › market-activity › stocksOutlook Therapeutics, Inc. Common Stock (OTLK) - Nasdaq

   www.nasdaq.com › market-activity › stocks

   • Cached

   Get the latest information on OTLK, a biotechnology company developing ophthalmic products. See bid and ask prices, earnings surprises, analyst ratings, revenue and more on Nasdaq.

5. www.google.com › finance › quoteOutlook Therapeutics Inc (OTLK) Stock Price & News - Google

   www.google.com › finance › quote

   • Cached

   Get the latest Outlook Therapeutics Inc (OTLK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

6. stockanalysis.com › stocks › otlkOutlook Therapeutics, Inc. (OTLK) - Stock Analysis

   stockanalysis.com › stocks › otlk

   • Cached

   3 days ago · OTLK is a biopharmaceutical company developing an ophthalmic formulation of bevacizumab for wet AMD. See the latest stock price, news, financials, statistics, forecast, profile, chart and more on Stock Analysis.

7. www.wsj.com › market-data › quotesOTLK | Outlook Therapeutics Inc. Stock Price & News - WSJ

   www.wsj.com › market-data › quotes

   • Cached

   View the latest Outlook Therapeutics Inc. (OTLK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

8. seekingalpha.com › symbol › OTLKOutlook Therapeutics, Inc. (OTLK) Stock Price, Quote, News ...

   seekingalpha.com › symbol › OTLK

   • Cached

   5 days ago · A high-level overview of Outlook Therapeutics, Inc. (OTLK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.